Trump abandons his FDA nominee, and Senate scraps vote on his NSF pick
- ID
- 48094
- Status
- summarized
- Published
- 19 Nov 2026, 6:08 AM
- Fetched
- 19 Nov 2026, 7:16 AM
- Provider
- Ars Technica
- Category
- technology
- Original URL
- https://arstechnica.com/health/2026/11/trump-abandons-his-fda-nominee-and-senate-scraps-vote-on-his-nsf-pick/
- Source URL
- https://feeds.arstechnica.com/arstechnica/index
Summary
- Score
- 1.5
- Created
- 19 Nov 2026, 7:17 AM
- Tags
- Audience
- founders
What happened
Ars Technica reports that the Trump administration dropped its FDA commissioner nominee, Heidi Overton, and the Senate cancelled a planned vote on the administration's NSF director pick. The excerpt is largely page navigation and an image caption: it confirms Overton's Sept 24, 2026 Senate HELP Committee confirmation hearing and a quote from Senator Bill Cassidy ("This time requires leadership and fortitude"), but names no NSF nominee and gives no reasons, dates, or next steps. The story carries 16 comments at time of capture.
Why it matters
There is not enough substance here to change a builder's decision. The text never names the NSF pick, states why either nomination failed, or describes any funding, grant, or policy consequence, so you cannot conclude anything concrete about US research funding, FDA review timelines for health-tech products, or agency posture toward AI. Skip it unless you can pull the full article or the underlying Senate record first.
Discussion angle
Only worth 60 seconds as a 'what we couldn't verify' note: the excerpt omits the NSF nominee's name and any stated reason for the withdrawal, so ask whether anyone has the full text before treating this as a research-funding signal.